Search

everythinglearnresearchcommunity

for

Search:↓

Inhibiting certain enzymes made female rats more sensitive to low-level pain.

Girls with PCOS have higher levels of certain androgens, which are linked to excess hair growth, but these androgens don't help diagnose PCOS.

People with cutaneous Lichen Planus are more likely to have Metabolic Syndrome and related conditions like high cholesterol, diabetes, and high blood pressure.

Vitamin D may help improve hormone levels in women with PCOS.

High YKL-40 levels predict early hair loss and hidden metabolic issues.

Loneliness raises stress levels in older African American men but not women.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

Low ferritin and Vitamin D levels may cause hair loss after COVID-19.

A 36-year-old woman with low potassium levels was found to have Cushing disease, and after treatment, her potassium levels normalized.

Neurosteroids help regulate oxytocin levels, especially during stress and pregnancy, to protect against premature labor.

Finasteride may slow down heart disease by lowering cholesterol and reducing inflammation.

The enzyme myo-inositol oxygenase is not linked to the cause of polycystic ovarian syndrome.

Adequate testosterone is crucial for men's health and quality of life, but its decline with age needs more research.

Lifestyle changes and environmental strategies can help address declining testosterone levels.

Certain genetic markers and low vitamin D3 levels are linked to male pattern baldness.

A balanced diet is crucial for normalizing hormone levels and managing obesity-related issues.

People with type 2 diabetes have lower vitamin E levels, especially older adults and females.

Low vitamin D in overweight teens is linked to higher leptin and lower adiponectin, affecting metabolism.

Higher leptin and lower vitamin D levels may contribute to male pattern baldness.

Allopregnanolone can reduce gut inflammation and normalize neurotransmitter levels after finasteride withdrawal.

Cyproterone acetate therapy improved hair loss and reduced testosterone levels in a menopausal woman.

Taking 1 mg finasteride for a year reduces dihydrotestosterone levels in men with early hair loss, but doesn't change their metabolic state.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Gingivitis may increase a hormone linked to ovarian function in women with a certain ovary condition, and treating gum disease could help manage it.

DGAT1 enzyme is crucial for healthy skin and hair by regulating retinoid levels.

New techniques improve understanding of cell cycle dynamics at the single-cell level.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Lovastatin doesn't improve lower urinary tract symptoms treatment.